Enhanced radiosensitization of enzalutamide via schedule dependent administration to androgen-sensitive prostate cancer cells-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Enhanced radiosensitization of enzalutamide via schedule dependent administration to androgen-sensitive prostate cancer cells

Published:2017-11-14 Issue:1 Volume:78 Page:64-75
ISSN:0270-4137
Container-title:The Prostate
language:en
Short-container-title:Prostate

Author:

Ghashghaei Maryam¹²,Paliouras Miltiadis¹²,Heravi Mitra¹,Bekerat Hamed³,Trifiro Mark¹⁴,Niazi Tamim M.¹²³,Muanza Thierry¹²³^ORCID

Affiliation:

1. Lady Davis Institute for Medical Research; Jewish General Hospital; Montreal Quebec Canada

2. Division of Experimental Medicine; McGill University; Montreal Quebec Canada

3. Department of Radiation Oncology; Jewish General Hospital; Quebec Canada

4. Division of Endocrinology; Jewish General Hospital; Montreal Quebec Canada

Publisher

Wiley

Subject

Urology,Oncology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1002/pros.23445/fullpdf

Reference54 articles.

1. Cancer statistics, 2013;Siegel;CA Cancer J Clin,2013

2. Treatment options after failure of radiation therapy-a review;Rukstalis;Rev Urol,2002

3. Androgen receptor signaling fuels DNA repair and radioresistance in prostate cancer;Bartek;Cancer Discov,2013

4. Bicalutamide ('Casodex') 150mg as adjuvant to radiotherapy in patients with localised or locally advanced prostate cancer: results from the randomised Early Prostate Cancer Programme;Tyrrell;Radiother Oncol,2005

5. Randomized non-inferiority trial of Bicalutamide and Dutasteride versus LHRH agonists for prostate volume reduction prior to I?125 permanent implant brachytherapy for prostate cancer;Gaudet;Radiother Oncol,2016

Cited by 40 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Novel hormone therapy and coordination of care in high-risk biochemically recurrent prostate cancer;Cancer Treatment Reviews;2024-01

2. Impact of sequencing of androgen receptor-signaling inhibition and radiotherapy in prostate cancer: importance of homologous recombination disruption;World Journal of Urology;2023-10-18

3. JNJ-64619178 radiosensitizes and suppresses fractionated ionizing radiation-induced neuroendocrine differentiation (NED) in prostate cancer;Frontiers in Oncology;2023-03-07

4. Phase II Randomized Study of Salvage Radiation Therapy Plus Enzalutamide or Placebo for High-Risk Prostate-Specific Antigen Recurrent Prostate Cancer After Radical Prostatectomy: The SALV-ENZA Trial;Journal of Clinical Oncology;2023-02-20

5. Mitochondrial metabolism: a predictive biomarker of radiotherapy efficacy and toxicity;Journal of Cancer Research and Clinical Oncology;2023-01-31

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3